Cargando…
High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer
SIMPLE SUMMARY: The detection of colorectal cancer (CRC) at an early stage is increasing due to the implementation of screening programs. Local excision of early CRC is potentially curative, however the identification of early lesions at high risk of regional metastases remains challenging, and grea...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945895/ https://www.ncbi.nlm.nih.gov/pubmed/35326703 http://dx.doi.org/10.3390/cancers14061552 |
_version_ | 1784674063166210048 |
---|---|
author | Boyaval, Fanny Dalebout, Hans Van Zeijl, René Wang, Wenjun Fariña-Sarasqueta, Arantza Lageveen-Kammeijer, Guinevere S. M. Boonstra, Jurjen J. McDonnell, Liam A. Wuhrer, Manfred Morreau, Hans Heijs, Bram |
author_facet | Boyaval, Fanny Dalebout, Hans Van Zeijl, René Wang, Wenjun Fariña-Sarasqueta, Arantza Lageveen-Kammeijer, Guinevere S. M. Boonstra, Jurjen J. McDonnell, Liam A. Wuhrer, Manfred Morreau, Hans Heijs, Bram |
author_sort | Boyaval, Fanny |
collection | PubMed |
description | SIMPLE SUMMARY: The detection of colorectal cancer (CRC) at an early stage is increasing due to the implementation of screening programs. Local excision of early CRC is potentially curative, however the identification of early lesions at high risk of regional metastases remains challenging, and greatly influencing therapy decision making. Variations in sugar molecules has been associated with development and progression in various cancer types including CRC. Therefore, we examined these sugar signatures, so-called N-glycans, in different stages of progression of CRC starting from epithelium to pre-cancerous and cancerous tissue. We report that the sugar signatures clearly differentiate each step of CRC progression, especially between pre-cancerous and cancerous tissue. We also observed some of the glycosylation signatures of the cancerous areas to be spreading into the tumor microenvironment. ABSTRACT: The increase incidence of early colorectal cancer (T1 CRC) last years is mainly due to the introduction of population-based screening for CRC. T1 CRC staging based on histological criteria remains challenging and there is high variability among pathologists in the scoring of these criteria. It is crucial to unravel the biology behind the progression of adenoma into T1 CRC. Glycomic studies have reported extensively on alterations of the N-glycomic pattern in CRC; therefore, investigating these alterations may reveal new insights into the development of T1 CRC. We used matrix-assisted laser desorption ionization (MALDI) mass spectrometry imaging (MSI) to spatially profile the N-glycan species in a cohort of pT1 CRC using archival formalin-fixed and paraffin-embedded (FFPE) material. To generate structural information on the observed N-glycans, CE-ESI-MS/MS was used in conjunction with MALDI-MSI. Relative intensities and glycosylation traits were calculated based on a panel of 58 N-glycans. Our analysis showed pronounced differences between normal epithelium, dysplastic, and carcinoma regions. High-mannose-type N-glycans were higher in the dysplastic region than in carcinoma, which correlates to increased proliferation of the cells. We observed changes in the cancer invasive front, including higher expression of α2,3-linked sialic acids which followed the glycosylation pattern of the carcinoma region. |
format | Online Article Text |
id | pubmed-8945895 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89458952022-03-25 High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer Boyaval, Fanny Dalebout, Hans Van Zeijl, René Wang, Wenjun Fariña-Sarasqueta, Arantza Lageveen-Kammeijer, Guinevere S. M. Boonstra, Jurjen J. McDonnell, Liam A. Wuhrer, Manfred Morreau, Hans Heijs, Bram Cancers (Basel) Article SIMPLE SUMMARY: The detection of colorectal cancer (CRC) at an early stage is increasing due to the implementation of screening programs. Local excision of early CRC is potentially curative, however the identification of early lesions at high risk of regional metastases remains challenging, and greatly influencing therapy decision making. Variations in sugar molecules has been associated with development and progression in various cancer types including CRC. Therefore, we examined these sugar signatures, so-called N-glycans, in different stages of progression of CRC starting from epithelium to pre-cancerous and cancerous tissue. We report that the sugar signatures clearly differentiate each step of CRC progression, especially between pre-cancerous and cancerous tissue. We also observed some of the glycosylation signatures of the cancerous areas to be spreading into the tumor microenvironment. ABSTRACT: The increase incidence of early colorectal cancer (T1 CRC) last years is mainly due to the introduction of population-based screening for CRC. T1 CRC staging based on histological criteria remains challenging and there is high variability among pathologists in the scoring of these criteria. It is crucial to unravel the biology behind the progression of adenoma into T1 CRC. Glycomic studies have reported extensively on alterations of the N-glycomic pattern in CRC; therefore, investigating these alterations may reveal new insights into the development of T1 CRC. We used matrix-assisted laser desorption ionization (MALDI) mass spectrometry imaging (MSI) to spatially profile the N-glycan species in a cohort of pT1 CRC using archival formalin-fixed and paraffin-embedded (FFPE) material. To generate structural information on the observed N-glycans, CE-ESI-MS/MS was used in conjunction with MALDI-MSI. Relative intensities and glycosylation traits were calculated based on a panel of 58 N-glycans. Our analysis showed pronounced differences between normal epithelium, dysplastic, and carcinoma regions. High-mannose-type N-glycans were higher in the dysplastic region than in carcinoma, which correlates to increased proliferation of the cells. We observed changes in the cancer invasive front, including higher expression of α2,3-linked sialic acids which followed the glycosylation pattern of the carcinoma region. MDPI 2022-03-18 /pmc/articles/PMC8945895/ /pubmed/35326703 http://dx.doi.org/10.3390/cancers14061552 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Boyaval, Fanny Dalebout, Hans Van Zeijl, René Wang, Wenjun Fariña-Sarasqueta, Arantza Lageveen-Kammeijer, Guinevere S. M. Boonstra, Jurjen J. McDonnell, Liam A. Wuhrer, Manfred Morreau, Hans Heijs, Bram High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer |
title | High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer |
title_full | High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer |
title_fullStr | High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer |
title_full_unstemmed | High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer |
title_short | High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer |
title_sort | high-mannose n-glycans as malignant progression markers in early-stage colorectal cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945895/ https://www.ncbi.nlm.nih.gov/pubmed/35326703 http://dx.doi.org/10.3390/cancers14061552 |
work_keys_str_mv | AT boyavalfanny highmannosenglycansasmalignantprogressionmarkersinearlystagecolorectalcancer AT dalebouthans highmannosenglycansasmalignantprogressionmarkersinearlystagecolorectalcancer AT vanzeijlrene highmannosenglycansasmalignantprogressionmarkersinearlystagecolorectalcancer AT wangwenjun highmannosenglycansasmalignantprogressionmarkersinearlystagecolorectalcancer AT farinasarasquetaarantza highmannosenglycansasmalignantprogressionmarkersinearlystagecolorectalcancer AT lageveenkammeijerguineveresm highmannosenglycansasmalignantprogressionmarkersinearlystagecolorectalcancer AT boonstrajurjenj highmannosenglycansasmalignantprogressionmarkersinearlystagecolorectalcancer AT mcdonnellliama highmannosenglycansasmalignantprogressionmarkersinearlystagecolorectalcancer AT wuhrermanfred highmannosenglycansasmalignantprogressionmarkersinearlystagecolorectalcancer AT morreauhans highmannosenglycansasmalignantprogressionmarkersinearlystagecolorectalcancer AT heijsbram highmannosenglycansasmalignantprogressionmarkersinearlystagecolorectalcancer |